'Everybody's talking about it': Metsera bidding war grips the obesity field

ATLANTA — Novo Nordisk and Pfizer made their presence known on the first day of the annual ObesityWeek conference. On Tuesday, the large drugmakers escalated their bidding war for Metsera, a Phase 2 biotech creating long ...